1. Home
  2. LDOS vs MRNA Comparison

LDOS vs MRNA Comparison

Compare LDOS & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leidos Holdings Inc.

LDOS

Leidos Holdings Inc.

HOLD

Current Price

$156.59

Market Cap

22.5B

Sector

Technology

ML Signal

HOLD

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$52.60

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDOS
MRNA
Founded
1969
2010
Country
United States
United States
Employees
47000
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
19.7B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
LDOS
MRNA
Price
$156.59
$52.60
Analyst Decision
Buy
Hold
Analyst Count
13
12
Target Price
$207.77
$34.27
AVG Volume (30 Days)
789.4K
5.3M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
1.10%
N/A
EPS Growth
20.82
21.77
EPS
11.14
N/A
Revenue
$17,174,000,000.00
$19,263,000,000.00
Revenue This Year
$5.59
$8.74
Revenue Next Year
$4.06
$16.18
P/E Ratio
$14.03
N/A
Revenue Growth
3.07
4.29
52 Week Low
$136.91
$22.28
52 Week High
$205.77
$59.55

Technical Indicators

Market Signals
Indicator
LDOS
MRNA
Relative Strength Index (RSI) 39.74 55.84
Support Level $154.52 $47.61
Resistance Level $165.66 $54.94
Average True Range (ATR) 3.75 2.59
MACD 0.47 -0.04
Stochastic Oscillator 47.57 73.61

Price Performance

Historical Comparison
LDOS
MRNA

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: